Dergiler / Turkish Journal of Biology / 2016 / Cilt: 40 - Sayı: 2

Underlying mechanisms and prospects of heart regeneration

Sayfa
276–289
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This review covers studies on the renewal of cardiomyocytes, the utilization of stem cells in myocardial therapies, and their future applications.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Findings in the last decade suggest that there is a considerable amount of cardiomyocyte turnover in the human heart throughout life, albeit not sufficient for heart regeneration following myocardial infarctions.
📊
Temel Bulgular & Veri:Similarly, neonatal mice have been recently shown to regenerate their heart following myocardial injuries.
💡
Sonuç & Katkı:This review covers studies on the renewal of cardiomyocytes, the utilization of stem cells in myocardial therapies, and their future applications.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Findings in the last decade suggest that there is a considerable amount of cardiomyocyte turnover in the human heart throughout life, albeit not sufficient for heart regeneration following myocardial infarctions. Only a few species are known to be remarkably efficient in cardiac regeneration. They restore lost cardiomyocytes via a process of cardiomyocyte dedifferentiation, which is followed by robust proliferation of cardiomyocytes and incorporation into the myocardium. Similarly, neonatal mice have been recently shown to regenerate their heart following myocardial injuries. Studies with a neonatal cardiac regeneration mouse model suggest that the major source of new cardiomyocytes is likely to be of cardiomyocyte origin, with the possibility of involvement of cardiac stem cells. To this end, numerous studies have been conducted on the induction of cardiac regeneration to shed light on the underlying mechanisms. This review covers studies on the renewal of cardiomyocytes, the utilization of stem cells in myocardial therapies, and their future applications.

🔖

Bu Makaleye Atıf Yap

KOCABAŞ, F., ASLAN, G. S., MISIR, D. G. (2022). Underlying mechanisms and prospects of heart regeneration. Turkish Journal of Biology, Cilt: 40 - Sayı: 2, 276–289. https://ajindex.com/articles/600366

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Agah R, Kirshenbaum LA, Abdellatif M, Truong LD, Chakraborty S, Michael LH, Schneider MD (1997). Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Invest 100: 2722–2728.
  2. Bader D, Oberpriller J (1979). Autoradiographic and electron microscopic studies of minced cardiac muscle regeneration in the adult newt, Notophthalmus viridescens. J Exp Zool 208: 177–193.
  3. Becker CG, Becker T (2008). Adult zebrafish as a model for successful central nervous system regeneration. Restor Neurol Neurosci 26: 71–80.
  4. Beigi F, Schmeckpeper J, Pow-Anpongkul P, Payne JA, Zhang L, Zhang Z, Huang J, Mirotsou M, Dzau VJ (2013). C3orf58, a novel paracrine protein, stimulates cardiomyocyte cell-cycle progression through the PI3K-AKT-CDK7 pathway. Circ Res 113: 372–380.
  5. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K et al. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763–776.
  6. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabé-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H et al. (2009). Evidence for cardiomyocyte renewal in humans. Science 324: 98–102.
  7. Bergmann O, Zdunek S, Frisén J, Bernard S (2012). Cardiomyocyte renewal in humans. Circ Res 324: 98–102.
  8. Bergmann O, Zdunek S, Frisén J, Bernard S, Druid H, Jovinge S (2012). Cardiomyocyte renewal in humans. Circ Res 110: e17– e18. Bernstein HS, Srivastava D (2012). Stem cell therapy for cardiac disease. Pediatr Res 71: 491–499.
  9. Bersell K, Arab S, Haring B, Kühn B (2009). Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 138: 257–270.
  10. Bicknell Katrina A, Coxon Carmen H, Brooks G (2004). Forced expression of the cyclin B1–CDC2 complex induces proliferation in adult rat cardiomyocytes. Biochem J 382: 411– 416. Borchardt T, Braun T (2007). Cardiovascular regeneration in nonmammalian model systems: what are the differences between newts and man? Thromb Haemost 98: 311–318.
  11. Bu L, Jiang X, Martin-Puig S, Caron L, Zhu S, Shao Y, Roberts DJ, Huang PL, Domian IJ, Chien KR (2009). Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 460: 113–117.
  12. Campa VM, Gutierrez-Lanza R, Cerignoli F, Diaz-Trelles R, Nelson B, Tsuji T, Barcova M, Jiang W, Mercola M (2008). Notch activates cell cycle reentry and progression in quiescent cardiomyocytes. J Cell Biol 18